Kanada - francoščina - Health Canada

glaxosmithkline inc - mépolizumab - solution - 100mg - mépolizumab 100mg - immunosuppressive agents

Kanada - francoščina - Health Canada

glaxosmithkline inc - mépolizumab - solution - 100mg - mépolizumab 100mg - immunosuppressive agents

Kanada - francoščina - Health Canada

astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists

Kanada - francoščina - Health Canada

teva canada limited - frémanézumab - solution - 225mg - frémanézumab 225mg - calcitonin-gene-related peptide (cgrp) antagonists

Kanada - francoščina - Health Canada

eli lilly canada inc - galcanÉzumab - solution - 100mg - galcanÉzumab 100mg - calcitonin-gene-related peptide (cgrp) antagonists

Kanada - francoščina - Health Canada

teva canada limited - frémanézumab - solution - 225mg - frémanézumab 225mg - calcitonin-gene-related peptide (cgrp) antagonists

Kanada - francoščina - Health Canada

hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 40mg; 80mg - trastuzumab 40mg; pertuzumab 80mg - antineoplastic agents

Kanada - francoščina - Health Canada

hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 60mg; 60mg - trastuzumab 60mg; pertuzumab 60mg - antineoplastic agents

Kanada - francoščina - Health Canada

glaxosmithkline inc - mépolizumab - solution - 40mg - mépolizumab 40mg

Kanada - francoščina - Health Canada

alexion pharma gmbh - ravulizumab - solution - 300mg - ravulizumab 300mg